Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8837 |
High Similarity |
NPD3027 |
Phase 3 |
0.8678 |
High Similarity |
NPD5283 |
Phase 1 |
0.8438 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8359 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8258 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8222 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8222 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8156 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.806 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8054 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8054 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7985 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7926 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD37 |
Approved |
0.7847 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.781 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7721 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7613 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7554 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7554 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7517 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD228 |
Approved |
0.75 |
Intermediate Similarity |
NPD1934 |
Approved |
0.745 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7426 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7402 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7344 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6896 |
Approved |
0.729 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5588 |
Approved |
0.723 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7192 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7192 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7172 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3384 |
Approved |
0.716 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD17 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7122 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7111 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1840 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7083 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7067 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7066 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7054 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7044 |
Intermediate Similarity |
NPD919 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7029 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6993 |
Remote Similarity |
NPD7526 |
Approved |
0.6993 |
Remote Similarity |
NPD52 |
Approved |
0.6993 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD7095 |
Approved |
0.6986 |
Remote Similarity |
NPD6353 |
Approved |
0.6984 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.698 |
Remote Similarity |
NPD1372 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD1608 |
Approved |
0.6977 |
Remote Similarity |
NPD3134 |
Approved |
0.6974 |
Remote Similarity |
NPD1511 |
Approved |
0.697 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD4140 |
Approved |
0.6963 |
Remote Similarity |
NPD3596 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD2563 |
Approved |
0.6962 |
Remote Similarity |
NPD2560 |
Approved |
0.6954 |
Remote Similarity |
NPD2677 |
Approved |
0.6947 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6933 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD4359 |
Approved |
0.6923 |
Remote Similarity |
NPD290 |
Approved |
0.6923 |
Remote Similarity |
NPD3537 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6918 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6788 |
Approved |
0.6914 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6913 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6909 |
Remote Similarity |
NPD7054 |
Approved |
0.6906 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6906 |
Remote Similarity |
NPD1281 |
Approved |
0.6905 |
Remote Similarity |
NPD3020 |
Approved |
0.6901 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6901 |
Remote Similarity |
NPD4624 |
Approved |
0.6899 |
Remote Similarity |
NPD5772 |
Approved |
0.6899 |
Remote Similarity |
NPD5773 |
Approved |
0.6899 |
Remote Similarity |
NPD2978 |
Approved |
0.6899 |
Remote Similarity |
NPD2977 |
Approved |
0.6897 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD3748 |
Approved |
0.6892 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6889 |
Remote Similarity |
NPD6671 |
Approved |
0.6887 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6884 |
Remote Similarity |
NPD2667 |
Approved |
0.6884 |
Remote Similarity |
NPD2668 |
Approved |
0.6884
|
Remote Similarity |
NPD5126 |
Approved |